Pharmacyclics (PCYC) Prices 2.2M Stock Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- S&P 500 ends marginally lower as investors focus on US-Iran war
Pharmacyclics (PCYC) Moves Lower on 2.2M Stock Offering
March 7, 2013 4:40 PM ESTPharmacyclics, Inc. (NASDAQ: PCYC) is ticking lower as the company announced a 2.2 million common stock offering. The stock is currently down over 1 percent.... More
Pharmacyclics (PCYC) Announces 2.2M Common Stock Offering
March 7, 2013 4:38 PM ESTPharmacyclics, Inc. (NASDAQ: PCYC) announced that it has commenced an underwritten registered public offering of 2,200,000 shares of its common stock, representing approximately 3.1% of the shares of common stock currently outstanding. All of the shares are being sold by Pharmacyclics.
J.P.... More
